Literature DB >> 30033669

Right aortic arch with situs solitus.

William N Evans1,2, Ruben J Acherman1,2, Dean Berthoty3, Gary A Mayman1,2, Michael L Ciccolo1,4, Sergio A Carrillo1,4, Humberto Restrepo1,2.   

Abstract

PATIENTS: We reviewed all patients evaluated at our center with situs solitus, levocardia, and a right aortic arch that were born between January 2000 and January 2018.
RESULTS: From our databases, we identified 204 patients. We excluded patients with a double aortic arch from analysis. Of the 204 patients, 103 (50%) were male. Of the 204 patients, 95 (47%) had an isolated right aortic arch. Of the 95 with an isolated right aortic arch, 4 (4%) had chromosome 22q11.2 deletion syndrome, and 89 (94%) had a vascular ring. Of the 204 patients, 109 (53%) had a surgical intracardiac malformation. Of the 109, with an associated surgical intracardiac malformation, 38 (35%) had chromosome 22q11.2 deletion syndrome, and 28 (26%) had a vascular ring. Overall, of the 204 patients, 200 (98%) had a vascular ring, an associated intracardiac malformation, or both. Prenatal detection was 85% (40/47) for the subset of patients born in Southern Nevada between January 2015 and January 2018.
CONCLUSION: this review, to best of our knowledge, reports one of largest series of right aortic arches in the literature. Data from our cohort demonstrates that a right aortic arch in situs solitus is almost always associated with pathology. Further, our center's right aortic arch prenatal detection rate exceeds previous reports.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  congenital heart disease; levocardia; prenatal detection; right aortic arch; situs solitus

Mesh:

Year:  2018        PMID: 30033669     DOI: 10.1111/chd.12623

Source DB:  PubMed          Journal:  Congenit Heart Dis        ISSN: 1747-079X            Impact factor:   2.007


  1 in total

1.  Ebstein Anomaly and Right Aortic Arch in Patient with Charge Syndrome.

Authors:  Inguna Lubaua; Madara Teraudkalna
Journal:  Medicina (Kaunas)       Date:  2021-11-13       Impact factor: 2.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.